BackImpel Pharmaceuticals Overview

Impel Pharmaceuticals Total Revenue

Revenue analysis for IMPL.

Quarterly Revenue

$5.02M
↑ 62.98% YoY

As of Sep 2023

Annual Revenue (TTM)

$20.99M
↑ 155.29% YoY

Trailing 12 months ending Sep 2023

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin